£2.62m
1 period on recordActive16004737Private limited companyLondon
TERNARY THERAPEUTICS LTD
Significant control: Christopher John Tame (25–50%)
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
Watch this company
Get an email when Companies House records a change for Ternary Therapeutics Ltd: status, filings, accounts, officers or owners. Free.
Not live yet: alerts start by 15 December 2026. We store your email and this company number only, for these alerts. If alerts don’t launch, we tell you and delete your address. Privacy
Coming soon · product and service lists
What does Ternary Therapeutics Ltd sell?
Registered activity: Research and experimental development on biotechnology (SIC 72110). We’re building product and service lists for UK companies. Get this one when it’s ready.
One email, only about this. If we don’t launch within 60 days we’ll tell you. Privacy
01
Summary
TERNARY THERAPEUTICS LTD is an active private limited company (company number 16004737) incorporated on 8 October 2024, registered in London. Its registered activity is research and experimental development on biotechnology (SIC 72110). Latest micro accounts cover the period ending 31 October 2025, showing net assets of £2.62m, with 8 employees on average. As micro-entity accounts, no profit and loss account is filed, so turnover and profit are not public.
Peer position · net assets
By net assets it sits in the top quarter of 603 comparable companies in London (median £440, upper quartile £92k).
02
Ownership and control
- Dr. Christopher John Tame
- owns 25–50% of shares
- holds 25–50% of voting rights
- Pace Ventures Enigma I Gmbh & Co. Kg
- owns 25–50% of shares
- holds 25–50% of voting rights
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.
03
Key dates
- Incorporated
- 8 October 20242 yrs ago
- Next accounts due
- 31 July 2027in 276 days
- Confirmation statement due
- 22 October 2027in 359 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
04
Activity
- SIC 72110
- Research and experimental development on biotechnology
- Accounts type
- Micro Entity
- Size band
- MicroCompanies Act thresholds
05
Financials
Not reported
Not disclosed
8
1 period on record| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 31 October 2025 | £2.62m | — | — | £77k | — | — | 8 |
Current ratio35Current assets ÷ creditors within one year
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing; micro-entity accounts contain no profit and loss account.
06
Filing and accounts signals
- Net assets above zeroNet assets £2,621,795 at 31 October 2025
- Current assets at least 1.5× creditors within one yearCurrent ratio 35.0
- Incorporated two to five years agoIncorporated 8 October 2024
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
07
Timeline
- Confirmation statement duein 359 days
- Next accounts duein 276 days
- Accounts period endNet assets £2.62m · micro accounts
- Incorporated
08
Similar companies in London
- BIOHEALTHCARENETWORKS LTDLondon · inc. Oct 2024
- FLIP THERAPEUTICS LTDLondon · inc. Oct 2024
- UMAMI BIOWORKS PTY. LTD.London · inc. Oct 2024
- VOID LIFESCIENCES LTDLondon · inc. Oct 2024
- MDX UK LTDLondon · inc. Oct 2024
- PNAS THERAPEUTICS LTDLondon · inc. Oct 2024
All companies incorporated on 8 October 2024 · in Oct 2024.
09
Reminders for TERNARY THERAPEUTICS LTD
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.